Company Filing History:
3 out of 832,912 Years Active: 2012-2013
Title: Volodymyr Mikhailovich Kysil: Innovator in Serotonin Receptor Antagonists
Introduction
Volodymyr Mikhailovich Kysil is a notable inventor based in Kyiv, Ukraine. He has made significant contributions to the field of pharmacology, particularly in the development of serotonin receptor antagonists. With a total of 3 patents, Kysil's work focuses on innovative compounds that have potential therapeutic applications.
Latest Patents
Kysil's latest patents include groundbreaking inventions related to serotonin 5-HT6 receptor antagonists. One of his notable patents describes novel substituted 3-sulfonyl-6,7,8,9-tetrahydropyrazolo[1,5-a]pyrido[4,3-e]pyrimidines. This invention outlines methods for the production and use of these compounds, which are aimed at treating various conditions and diseases of the central nervous system in humans and warm-blooded animals. Another significant patent involves 2-amino-3-sulphonyl-tetrahydro-pyrazolo[1,5-A]pyrido-pyrimidine antagonists, which also target serotonin 5-HT6 receptors. These compounds are designed to address cognitive and neurodegenerative diseases, showcasing Kysil's commitment to advancing medical science.
Career Highlights
Throughout his career, Kysil has demonstrated a strong focus on innovative drug development. His work has contributed to the understanding of serotonin receptors and their role in various neurological conditions. Kysil's research has the potential to lead to new treatment options for patients suffering from disorders related to the central nervous system.
Collaborations
Kysil has collaborated with notable colleagues, including Andrey Alexandrovich Ivashchenko and Nikolay Filippovich Savchuk. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical compounds.
Conclusion
Volodymyr Mikhailovich Kysil is a prominent inventor whose work in serotonin receptor antagonists is paving the way for innovative treatments in pharmacology. His contributions are significant in the ongoing quest to improve health outcomes for individuals with central nervous system disorders.